The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus: An Expert Panel Summary
Abstract
Abstract—The rapid development of angiogenic growth factor therapy for patients with advanced ischemic heart disease over the last 5 years offers hope of a new treatment strategy based on generation of new blood supply in the diseased heart. However, as the field of therapeutic coronary angiogenesis is maturing from basic and preclinical investigations to clinical trials, many new and presently unresolved issues are coming into focus. These include in-depth understanding of the biology of angiogenesis, selection of appropriate patient populations for clinical trials, choice of therapeutic end points and means of their assessment, choice of therapeutic strategy (gene versus protein delivery), route of administration, and the side effect profile. The present article presents a summary statement of a panel of experts actively working in the field, convened by the Angiogenesis Foundation and the Angiogenesis Research Center during the 72nd meeting of the American Heart Association to define and achieve a consensus on the challenges facing development of therapeutic angiogenesis for coronary disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
Measuring Health-Related Quality of Life
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-8-199304150-00009 · Cited by 3,958
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life
Patrick, D. L., & Deyo, R. A. (1989) · Medical Care · doi:10.1097/00005650-198903001-00018 · Cited by 1,790
Spertus, J. A., Winder, J. A., Dewhurst, T. A., Deyo, R. A., Prodzinski, J., McDonnell, M., & Fihn, S. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00397-9 · Cited by 1,385
Adamis, A. P., Miller, J. W., Bernal, M.-T., D'Amico, D. J., Folkman, J., Yeo, T.-K., & Yeo, K.-T. (1994) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75794-0 · Cited by 1,296
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,036
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · cited 1×
“Issues The advantages of coronary angiography in trials of therapeutic angiogenesis relate to its ability to (1) assist in stratification of disease severity, (2) assist in patient selection and randomization, (3) identify the extent of disease progression (an adverse effect of treatment), and (4) document the appeara…”
BackgroundLosordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
TORRANCE, G. W., FEENY, D. H., FURLONG, W. J., BARR, R. D., ZHANG, Y., & WANG, Q. (1996) · Medical Care · doi:10.1097/00005650-199607000-00004 · Cited by 900
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Age-Dependent Impairment of Angiogenesis
Rivard, A., Fabre, J.-E., Silver, M., Chen, D., Murohara, T., Kearney, M., Magner, M., Asahara, T., & Isner, J. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.111 · Cited by 771
Vanoverschelde, J. L., Wijns, W., Depré, C., Essamri, B., Heyndrickx, G. R., Borgers, M., Bol, A., & Melin, J. A. (1993) · Circulation · doi:10.1161/01.cir.87.5.1513 · Cited by 707
Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
Aiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Self-citationWidespread long-term gene transfer to mouse skeletal muscles and heart.
Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., & Briand, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115902 · Cited by 580
Schumacher, B., Pecher, P., von Specht, B. U., & Stegmann, T. (1998) · Circulation · doi:10.1161/01.cir.97.7.645 · Cited by 531
Self-citationVascular development: cellular and molecular regulation
Beck, L., & D'Amore, P. A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141503 · Cited by 519
Giordano, F. J., Ping, P., McKirnan, M. D., Nozaki, S., Demaria, A. N., Dillmann, W. H., Mathieu-Costello, O., & Hammond, H. K. (1996) · Nature Medicine · doi:10.1038/nm0596-534 · Cited by 486
Self-citationHow should we measure function in patients with chronic heart and lung disease?
Guyatt, G. H., Thompson, P. J., Berman, L. B., Sullivan, M. J., Townsend, M., Jones, N. L., & Pugsley, S. O. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90035-9 · Cited by 432
Monitoring the quality of life in patients with coronary artery disease
Spertus, J. A., Winder, J. A., Dewhurst, T. A., Deyo, R. A., & Fihn, S. D. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90555-x · Cited by 414
Laham, R. J., Sellke, F. W., Edelman, E. R., Pearlman, J. D., Ware, J. A., Brown, D. L., Gold, J. P., & Simons, M. (1999) · Circulation · doi:10.1161/01.cir.100.18.1865 · Cited by 409
Self-citationTsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S. T., Passeri, J., Horowitz, J. R., Symes, J. F., & Isner, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.12.3281 · Cited by 389
PR39, a peptide regulator of angiogenesis
Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R. D., et al. (2000) · Nature Medicine · doi:10.1038/71527 · Cited by 386
Self-citationFrazier, O. H., March, R. J., & Horvath, K. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411402 · Cited by 373
Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque
Libby, P., Sukhova, G., Lee, R. T., & Galis, Z. S. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199500252-00003 · Cited by 371
Nabel, E. G., Yang, Z.-Y., Plautz, G., Forough, R., Zhan, X., Haudenschild, C. C., Maciag, T., & Nabel, G. J. (1993) · Nature · doi:10.1038/362844a0 · Cited by 367
Allen, K. B., Dowling, R. D., Fudge, T. L., Schoettle, G. P., Selinger, S. L., Gangahar, D. M., Angell, W. W., Petracek, M. R., Shaar, C. J., & O’Neill, W. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411403 · Cited by 364
Controlled and modulated release of basic fibroblast growth factor
Edelman, E. R., Mathiowitz, E., Langer, R., & Klagsbrun, M. (1991) · Biomaterials · doi:10.1016/0142-9612(91)90107-l · Cited by 363
Gould, K. L., Martucci, J. P., Goldberg, D. I., Hess, M. J., Edens, R. P., Latifi, R., & Dudrick, S. J. (1994) · Circulation · doi:10.1161/01.cir.89.4.1530 · Cited by 336
Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis
Pearlman, J. D., Hibberd, M. G., Chuang, M. L., Harada, K., Lopez, J. J., Gladstone, S. R., Friedman, M., Sellke, F. W., & Simons, M. (1995) · Nature Medicine · doi:10.1038/nm1095-1085 · Cited by 326
Self-citationAngiogenesis in ischemic heart disease
Ware, J. A., & Simons, M. (1997) · Nature Medicine · doi:10.1038/nm0297-158 · Cited by 323
Self-citationCaptopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Dewey, R. A., Morrissey, G., Cowsill, C. M., Stone, D., Bolognani, F., Dodd, N. J. F., Southgate, T. D., Klatzmann, D., Lassmann, H., Castro, M. G., et al. (1999) · Nature Medicine · doi:10.1038/15207 · Cited by 311
Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.
Harada, K., Grossman, W., Friedman, M., Edelman, E. R., Prasad, P. V., Keighley, C. S., Manning, W. J., Sellke, F. W., & Simons, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117378 · Cited by 304
Self-citationHendel, R. C., Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F. J., Simons, M., & Bonow, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.2.118 · Cited by 295
Self-citationAngiogenesis in human coronary atherosclerotic plaques.
O’Brien, E. R., Garvin, M. R., Dev, R., Stewart, D. K., Hinohara, T., Simpson, J. B., & Schwartz, S. M. (1994) · PubMed · Cited by 271
Edelman, E. R., Nugent, M. A., & Karnovsky, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1513 · Cited by 266
Angiogenesis inhibition by minocycline.
Tamargo, R. J., Bok, R., & Brem, H. (1991) · PubMed · Cited by 250
Hypotensive Activity of Fibroblast Growth Factor
Cuevas, P., Carceller, F., Ortega, S., Zazo, M., Nieto, I., & Giménez-Gallego, G. (1991) · Science · doi:10.1126/science.1957172 · Cited by 244
Schultz, A., Lavie, L., Hochberg, I., Beyar, R., Stone, T., Skorecki, K., Lavie, P., Roguin, A., & Levy, A. P. (1999) · Circulation · doi:10.1161/01.cir.100.5.547 · Cited by 228
Health Status Measures: An Overview and Guide for Selection
Bergner, M., & Rothman, M. L. (1987) · Annual Review of Public Health · doi:10.1146/annurev.pu.08.050187.001203 · Cited by 226
Coronary collateral development in swine after coronary artery occlusion.
White, F. C., Carroll, S. M., Magnet, A., & Bloor, C. M. (1992) · Circulation Research · doi:10.1161/01.res.71.6.1490 · Cited by 213
Laitinen, M., Hartikainen, J., Hiltunen, M. O., Eranen, J., Kiviniemi, M., Narvanen, O., Makinen, K., Manninen, H., Syvanne, M., Martin, J. F., et al. (2000) · Human Gene Therapy · doi:10.1089/10430340050016003 · Cited by 212
Baller, D., Notohamiprodjo, G., Gleichmann, U., Holzinger, J., Weise, R., & Lehmann, J. (1999) · Circulation · doi:10.1161/01.cir.99.22.2871 · Cited by 204
Van Belle, E., Rivard, A., Chen, D., Silver, M., Bunting, S., Ferrara, N., Symes, J. F., Bauters, C., & Isner, J. M. (1997) · Circulation · doi:10.1161/01.cir.96.8.2667 · Cited by 199
VEGF administration in chronic myocardial ischemia in pigs
Lopez, J. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00136-9 · Cited by 188
Researchers and regulators reflect on first gene therapy death
Hollon, T. (2000) · Nature Medicine · doi:10.1038/71545 · Cited by 175
Coronary Artery Bypass Surgery
Jenkins, C. D. (1983) · JAMA · doi:10.1001/jama.1983.03340060060027 · Cited by 164
COX‐2 Inhibitors: A New Class of Antiangiogenic Agents
Masferrer, J. L., Koki, A. T., & Seibert, K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08726.x · Cited by 159
Byrnes, A. P., MacLaren, R. E., & Charlton, H. M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03045.1996 · Cited by 156
Pipili‐Synetos, E., Papageorgiou, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karakiulakis, G., & Maragoudakis, M. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16670.x · Cited by 151
Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls
Miosge, N., Sasaki, T., & Timpl, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1743 · Cited by 143
Mühlhauser, J., Jones, M., Yamada, I., Cirielli, C., Lemarchand, P., GLOE, T. R., Bewig, B., Signoretti, S., Crystal, R. G., & Capogrossi, M. C. (1996) · PubMed · Cited by 124
Laham, R. J., Rezaee, M., Post, M. J., Sellke, F. W., Braeckman, R. A., Hung, D., & Simons, M. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)11823-5 · Cited by 108
Self-citationThe Canadian Cardiovascular Society Grading Scale for Angina Pectoris: Is It Time for Refinements?
Cox, J. L., & Naylor, C. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-8-677 · Cited by 79
Wersto, R. P., Rosenthal, E. R., Seth, P. K., Eissa, N. T., & Donahue, R. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9491-9502.1998 · Cited by 76
Preclinical and Clinical Studies with Recombinant Human Basic Fibroblast Growth Factor
Mazué, G., Bertolero, F., Jacob, C., Sarmientos, P., & Roncucci, R. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb49043.x · Cited by 72
New Activity of Spironolactone: Inhibition of Angiogenesis In Vitro and In Vivo
Klauber, N., Browne, F., Anand‐Apte, B., & D’Amato, R. J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2566 · Cited by 69
The relationship between exercise tolerance and quality of life in angina pectoris
Wiklund, I. E., Comerford, M. B., & Dimenäs, E. (1991) · Clinical Cardiology · doi:10.1002/clc.4960140306 · Cited by 66
Ohmoto, Y., Wood, M. J. A., Charlton, H. M., Kajiwara, K., Perry, V. H., & Wood, K. J. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300851 · Cited by 48
Chan, S. Y., Li, K., Piccotti, J. R., Louie, M. C., Judge, T. A., Turka, L. A., EICHWALD, E. J., & Bishop, D. K. (1999) · Nature Medicine · doi:10.1038/13467 · Cited by 47
Prognosis in Congestive Heart Failure
DOMANSKI, M. J., Garg, R., & Yusuf, S. (1994) · Springer eBooks · doi:10.1007/978-1-4613-8315-4_33 · Cited by 34
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Hydrogels for tissue engineering: scaffold design variables and applications
Drury, J. L., & Mooney, D. J. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00340-5 · Cited by 5,136
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., Amano, K., Kishimoto, Y., Yoshimoto, K., Akashi, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09670-8 · Cited by 1,734
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Metadata
- Authors
- Simons, M., Bonow, R. O., Chronos, N. A., Cohen, D. J., Giordano, F. J., Hammond, H. K., Laham, R. J., Li, W., Pike, M., Sellke, F. W., Stegmann, T. J., Udelson, J. E., & Rosengart, T. K.
- Venue
- Circulation
- Published
- 2000-09-12
- Volume
- 102
- Issue
- 11
- Pages
- E73-86
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2137982969
- Cited by
- 459
- References
- 68
- FWCI
- 38.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.